Genetic landscape of phospholamban cardiomyopathies
Phospholamban (PLN) is a key regulator of cardiac muscle contractility and has become a central focus in the study of cardiac disease. Variants in the PLN gene have been identified in patients with a wide range of phenotypes, including hypertrophic, dilated, and arrhythmogenic cardiomyopathies. The...
Saved in:
| Main Authors: | Elizabeth Vafiadaki, Ishita Chaudhari, Keisha Mireia Soliman, Aristides G. Eliopoulos, Evangelia G. Kranias, Despina Sanoudou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1626242/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of a novel, pathogenic CREBBP variant in a patient with Menke-Hennekam syndrome: a Case Report
by: Anna Μaria Anastasiou, et al.
Published: (2025-08-01) -
Implementation of genetic testing for heritable cardiac conditions: A scoping review
by: Ana Morales, et al.
Published: (2025-01-01) -
Genetic landscape of hypertrophic cardiomyopathy in Hong Kong Chinese population
by: Derek P. H. Lee, et al.
Published: (2025-05-01) -
Correction: Genetic landscape of hypertrophic cardiomyopathy in Hong Kong Chinese population
by: Derek P. H. Lee, et al.
Published: (2025-06-01) -
Spectrum of desmosomal gene variations in patients with arrhythmogenic right ventricular cardiomyopathy
by: A. G. Shestak, et al.
Published: (2021-11-01)